{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:47:28Z","timestamp":1790621248436,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000887","name":"Huntington\u2019s Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA07315"],"award-info":[{"award-number":["T32DA07315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00415-018-8940-6","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T10:09:06Z","timestamp":1530180546000},"page":"551-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Multiple clinical features of Huntington\u2019s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration"],"prefix":"10.1007","volume":"266","author":[{"given":"Sonia","family":"Podvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly T.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mosier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-7024","authenticated-orcid":false,"given":"Vivian","family":"Hook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"8940_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"8940_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/exnr.1998.7006","volume":"157","author":"A Peters\u00e9n","year":"1999","unstructured":"Peters\u00e9n A, Mani K, Brundin P (1999) Recent advances on the pathogenesis of Huntington\u2019s disease. Exp Neurol 157:1\u201318. \n                    https:\/\/doi.org\/10.1006\/exnr.1998.7006","journal-title":"Exp Neurol"},{"key":"8940_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"8940_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981. \n                    https:\/\/doi.org\/10.1152\/physrev.00041.2009","journal-title":"Physiol Rev"},{"key":"8940_CR5","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005. \n                    https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Nat Rev Dis Primers"},{"key":"8940_CR6","first-page":"971","volume":"72","author":"The Huntington","year":"1999","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1999) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"8940_CR7","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gay\u00e1n J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha J-H, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O\u2019Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS, Landwehrmeyer B, U.S.-Venezuela Collaborative Research Project (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA 101:3498\u20133503. \n                    https:\/\/doi.org\/10.1073\/pnas.0308679101","journal-title":"Proc Natl Acad Sci USA"},{"key":"8940_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4:398\u2013403. \n                    https:\/\/doi.org\/10.1038\/ng0893-398","journal-title":"Nat Genet"},{"key":"8940_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1212\/WNL.48.2.394","volume":"48","author":"EH Aylward","year":"1997","unstructured":"Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA (1997) Longitudinal change in basal ganglia volume in patients with Huntington\u2019s disease. Neurology 48:394\u2013399","journal-title":"Neurology"},{"key":"8940_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.46.2.527","volume":"46","author":"J Brandt","year":"1996","unstructured":"Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA (1996) Trinucleotide repeat length and clinical progression in Huntington\u2019s disease. Neurology 46:527\u2013531","journal-title":"Neurology"},{"key":"8940_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.410360412","volume":"36","author":"SN Illarioshkin","year":"1994","unstructured":"Illarioshkin SN, Igarashi S, Onodera O, Markova ED, Nikolskaya NN, Tanaka H, Chabrashwili TZ, Insarova NG, Endo K, Ivanova-Smolenskaya IA (1994) Trinucleotide repeat length and rate of progression of Huntington\u2019s disease. Ann Neurol 36:630\u2013635. \n                    https:\/\/doi.org\/10.1002\/ana.410360412","journal-title":"Ann Neurol"},{"key":"8940_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/jmg.31.11.872","volume":"31","author":"K Kieburtz","year":"1994","unstructured":"Kieburtz K, MacDonald M, Shih C, Feigin A, Steinberg K, Bordwell K, Zimmerman C, Srinidhi J, Sotack J, Gusella J (1994) Trinucleotide repeat length and progression of illness in Huntington\u2019s disease. J Med Genet 31:872\u2013874","journal-title":"J Med Genet"},{"key":"8940_CR13","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"J-M Lee","year":"2012","unstructured":"Lee J-M, Ramos EM, Lee J-H, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJA, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB, REGISTRY study of the European Huntington\u2019s Disease Network, Myers RH, HD-MAPS Study Group, MacDonald ME, Gusella JF, COHORT study of the HSG (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690\u2013695. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318249f683","journal-title":"Neurology"},{"key":"8940_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10654-007-9157-7","volume":"22","author":"T Pekmezovic","year":"2007","unstructured":"Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M, Romac S, Kostic VS (2007) Survival of Huntington\u2019s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol 22:523\u2013526. \n                    https:\/\/doi.org\/10.1007\/s10654-007-9157-7","journal-title":"Eur J Epidemiol"},{"key":"8940_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S0317167100012671","volume":"39","author":"C Rinaldi","year":"2012","unstructured":"Rinaldi C, Salvatore E, Giordano I, De Matteis S, Tucci T, Cinzia VR, Rossi F, Castaldo I, Morra VB, Di Maio L, Filla A, De Michele G (2012) Predictors of survival in a Huntington\u2019s disease population from southern Italy. Can J Neurol Sci J Can Sci Neurol 39:48\u201351","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"8940_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/mds.23108","volume":"25","author":"MK Trembath","year":"2010","unstructured":"Trembath MK, Horton ZA, Tippett L, Hogg V, Collins VR, Churchyard A, Velakoulis D, Roxburgh R, Delatycki MB (2010) A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord Off J Mov Disord Soc 25:1444\u20131450. \n                    https:\/\/doi.org\/10.1002\/mds.23108","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2008.09.029","volume":"276","author":"H Lipe","year":"2009","unstructured":"Lipe H, Bird T (2009) Late onset Huntington Disease: clinical and genetic characteristics of 34 cases. J Neurol Sci 276:159\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.jns.2008.09.029","journal-title":"J Neurol Sci"},{"key":"8940_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/jmg.2006.045153","volume":"44","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gay\u00e1n J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington\u2019s disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44\u201350. \n                    https:\/\/doi.org\/10.1136\/jmg.2006.045153","journal-title":"J Med Genet"},{"key":"8940_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","volume":"71","author":"JM Andresen","year":"2007","unstructured":"Andresen JM, Gay\u00e1n J, Djouss\u00e9 L, Roberts S, Brocklebank D, Cherny SS, US-Venezuela Collaborative Research Group, HD MAPS Collaborative Research Group, Cardon LR, Gusella JF, MacDonald ME, Myers RH, Housman DE, Wexler NS (2007) The relationship between CAG repeat length and age of onset differs for Huntington\u2019s disease patients with juvenile onset or adult onset. Ann Hum Genet 71:295\u2013301. \n                    https:\/\/doi.org\/10.1111\/j.1469-1809.2006.00335.x","journal-title":"Ann Hum Genet"},{"key":"8940_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E, Predict-HD Investigators of the Huntington Study Group (2006) Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 63:883\u2013890. \n                    https:\/\/doi.org\/10.1001\/archneur.63.6.883","journal-title":"Arch Neurol"},{"key":"8940_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, Predict-HD Investigators and Coordinators of the Huntington Study Group (2008) Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79:874\u2013880. \n                    https:\/\/doi.org\/10.1136\/jnnp.2007.128728","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8940_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1034\/j.1399-0004.2002.610607.x","volume":"61","author":"ME Alonso","year":"2002","unstructured":"Alonso ME, Yescas P, Rasmussen A, Ochoa A, Mac\u00edas R, Ruiz I, Su\u00e1stegui R (2002) Homozygosity in Huntington\u2019s disease: new ethical dilemma caused by molecular diagnosis. Clin Genet 61:437\u2013442","journal-title":"Clin Genet"},{"key":"8940_CR23","first-page":"172","volume":"36","author":"A D\u00fcrr","year":"1999","unstructured":"D\u00fcrr A, Hahn-Barma V, Brice A, P\u00eacheux C, Dod\u00e9 C, Feingold J (1999) Homozygosity in Huntington\u2019s disease. J Med Genet 36:172\u2013173","journal-title":"J Med Genet"},{"key":"8940_CR24","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-L\u00e9vi A-C, Simpson SA, Delatycki M, Maglione V, Hayden MR, Donato SD (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain J Neurol 126:946\u2013955","journal-title":"Brain J Neurol"},{"key":"8940_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","volume":"25","author":"AD Ha","year":"2012","unstructured":"Ha AD, Fung VSC (2012) Huntington\u2019s disease. Curr Opin Neurol 25:491\u2013498. \n                    https:\/\/doi.org\/10.1097\/WCO.0b013e3283550c97","journal-title":"Curr Opin Neurol"},{"key":"8940_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/mds.21988","volume":"23","author":"B Ravina","year":"2008","unstructured":"Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP (2008) The relationship between CAG repeat length and clinical progression in Huntington\u2019s disease. Mov Disord Off J Mov Disord Soc 23:1223\u20131227. \n                    https:\/\/doi.org\/10.1002\/mds.21988","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mds.24024","volume":"27","author":"A Rosenblatt","year":"2012","unstructured":"Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA (2012) Age, CAG repeat length, and clinical progression in Huntington\u2019s disease. Mov Disord Off J Mov Disord Soc 27:272\u2013276. \n                    https:\/\/doi.org\/10.1002\/mds.24024","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt A, Liang K-Y, Zhou H, Abbott MH, Gourley LM, Margolis RL, Brandt J, Ross CA (2006) The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66:1016\u20131020. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000204230.16619.d9","journal-title":"Neurology"},{"key":"8940_CR29","first-page":"452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I (2000) Rate of functional decline in Huntington\u2019s disease. Huntingt Study Group Neurol 54:452\u2013458","journal-title":"Huntingt Study Group Neurol"},{"key":"8940_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/mds.25964","volume":"29","author":"JC Stout","year":"2014","unstructured":"Stout JC, Queller S, Baker KN, Cowlishaw S, Sampaio C, Fitzer-Attas C, Borowsky B, HD-CAB Investigators (2014) HD-CAB: a cognitive assessment battery for clinical trials inHuntington\u2019s disease 1,2,3. Mov Disord Off J Mov Disord Soc 29:1281\u20131288. \n                    https:\/\/doi.org\/10.1002\/mds.25964","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, TRACK-HD Investigators (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637\u2013649. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70088-7","journal-title":"Lancet Neurol"},{"key":"8940_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","volume":"65","author":"JCH van Oostrom","year":"2005","unstructured":"van Oostrom JCH, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Duin L, Pruim J, Roos RC, Leenders KL (2005) Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology 65:941\u2013943. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000176071.08694.cc","journal-title":"Neurology"},{"key":"8940_CR33","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","volume":"71","author":"NA Aziz","year":"2008","unstructured":"Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, EHDI Study Group, Roos R (2008) Weight loss in Huntington disease increases with higher CAG repeatnumber. Neurology 71:1506\u20131513. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000334276.09729.0e","journal-title":"Neurology"},{"key":"8940_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ana.25007","volume":"82","author":"JMM van der Burg","year":"2017","unstructured":"van der Burg JMM, Gardiner SL, Ludolph AC, Landwehrmeyer GB, Roos RAC, Aziz NA (2017) Body weight is a robust predictor of clinical progression in Huntington disease. Ann Neurol 82:479\u2013483. \n                    https:\/\/doi.org\/10.1002\/ana.25007","journal-title":"Ann Neurol"},{"key":"8940_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","volume":"98","author":"JW Keum","year":"2016","unstructured":"Keum JW, Shin A, Gillis T, Mysore JS, Abu Elneel K, Lucente D, Hadzi T, Holmans P, Jones L, Orth M, Kwak S, MacDonald ME, Gusella JF, Lee J-M (2016) The HTT CAG-expansion mutation determines age at death but not disease duration in huntington disease. Am J Hum Genet 98:287\u2013298. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2015.12.018","journal-title":"Am J Hum Genet"},{"key":"8940_CR36","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/WNL.0b013e31826e9a5d","volume":"79","author":"TC Hadzi","year":"2012","unstructured":"Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH, Vonsattel J-P (2012) Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology 79:1708\u20131715. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31826e9a5d","journal-title":"Neurology"},{"key":"8940_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"8940_CR38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s004150050518","volume":"246","author":"B Culjkovic","year":"1999","unstructured":"Culjkovic B, Stojkovic O, Vojvodic N, Svetel M, Rakic L, Romac S, Kostic V (1999) Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington\u2019s disease. J Neurol 246:1090\u20131093","journal-title":"J Neurol"},{"key":"8940_CR39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney JB, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41:689\u2013692. \n                    https:\/\/doi.org\/10.1002\/ana.410410521","journal-title":"Ann Neurol"},{"key":"8940_CR40","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/mds.23762","volume":"26","author":"HD Rosas","year":"2011","unstructured":"Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM (2011) A tale of two factors: what determines the rate of progression in Huntington\u2019s disease? A longitudinal MRI study. Mov Disord Off J Mov Disord Soc 26:1691\u20131697. \n                    https:\/\/doi.org\/10.1002\/mds.23762","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/brain.2014.0271","volume":"4","author":"KA Koenig","year":"2014","unstructured":"Koenig KA, Lowe MJ, Harrington DL, Lin J, Durgerian S, Mourany L, Paulsen JS, Rao SM, PREDICT-HD Investigators of the Huntington Study Group (2014) Functional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease. Brain Connect 4:535\u2013546. \n                    https:\/\/doi.org\/10.1089\/brain.2014.0271","journal-title":"Brain Connect"},{"key":"8940_CR42","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1002\/hbm.23713","volume":"38","author":"D Wu","year":"2017","unstructured":"Wu D, Faria AV, Younes L, Mori S, Brown T, Johnson H, Paulsen JS, Ross CA, Miller MI, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2017) Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington\u2019s disease. Hum Brain Mapp 38:5035\u20135050. \n                    https:\/\/doi.org\/10.1002\/hbm.23713","journal-title":"Hum Brain Mapp"},{"key":"8940_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.biopsych.2011.07.030","volume":"71","author":"EH Aylward","year":"2012","unstructured":"Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, Long JD, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2012) Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry 71:822\u2013828. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2011.07.030","journal-title":"Biol Psychiatry"},{"key":"8940_CR44","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1002\/hbm.23332","volume":"37","author":"M Orth","year":"2016","unstructured":"Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Kl\u00f6ppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, Rothwell JC, Langbehn D, Tabrizi SJ, TRACK-On Investigators (2016) Natural variation in sensory-motor white matter organization influences manifestations of Huntington\u2019s disease. Hum Brain Mapp 37:4615\u20134628. \n                    https:\/\/doi.org\/10.1002\/hbm.23332","journal-title":"Hum Brain Mapp"},{"key":"8940_CR45","doi-asserted-by":"publisher","first-page":"e73280","DOI":"10.1371\/journal.pone.0073280","volume":"8","author":"O Phillips","year":"2013","unstructured":"Phillips O, Sanchez-Castaneda C, Elifani F, Maglione V, Di Pardo A, Caltagirone C, Squitieri F, Sabatini U, Di Paola M (2013) Tractography of the corpus callosum in Huntington\u2019s disease. PloS One 8:e73280. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0073280","journal-title":"PloS One"},{"key":"8940_CR46","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","volume":"39","author":"A Ciarmiello","year":"2012","unstructured":"Ciarmiello A, Giovacchini G, Orobello S, Bruselli L, Elifani F, Squitieri F (2012) 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging 39:1030\u20131036. \n                    https:\/\/doi.org\/10.1007\/s00259-012-2114-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8940_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.21008","volume":"32","author":"M Politis","year":"2011","unstructured":"Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: a multimodal imaging study. Hum Brain Mapp 32:258\u2013270. \n                    https:\/\/doi.org\/10.1002\/hbm.21008","journal-title":"Hum Brain Mapp"},{"key":"8940_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.neuroimage.2012.07.009","volume":"63","author":"K Reetz","year":"2012","unstructured":"Reetz K, Romanzetti S, Dogan I, Sa\u00df C, Werner CJ, Schiefer J, Schulz JB, Shah NJ (2012) Increased brain tissue sodium concentration in Huntington\u2019s disease\u2014a sodium imaging study at 4 T. NeuroImage 63:517\u2013524. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2012.07.009","journal-title":"NeuroImage"},{"key":"8940_CR49","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","volume":"71","author":"DS Russell","year":"2014","unstructured":"Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL (2014) The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. JAMA Neurol 71:1520\u20131528. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2014.1954","journal-title":"JAMA Neurol"},{"key":"8940_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","volume":"51","author":"K Van Laere","year":"2010","unstructured":"Van Laere K, Casteels C, Dhollander I, Goffin K, Grachev I, Bormans G, Vandenberghe W (2010) Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo. J Nucl Med Off Publ Soc Nucl Med 51:1413\u20131417. \n                    https:\/\/doi.org\/10.2967\/jnumed.110.077156","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"8940_CR51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","volume":"43","author":"G Pagano","year":"2016","unstructured":"Pagano G, Niccolini F, Politis M (2016) Current status of PET imaging in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging 43:1171\u20131182. \n                    https:\/\/doi.org\/10.1007\/s00259-016-3324-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8940_CR52","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00259-014-2724-8","volume":"41","author":"A Matusch","year":"2014","unstructured":"Matusch A, Saft C, Elmenhorst D, Kraus PH, Gold R, Hartung H-P, Bauer A (2014) Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington\u2019s disease. Eur J Nucl Med Mol Imaging 41:1210\u20131220. \n                    https:\/\/doi.org\/10.1007\/s00259-014-2724-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Pt 9","key":"8940_CR53","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/brain\/120.9.1569","volume":"120","author":"RA Weeks","year":"1997","unstructured":"Weeks RA, Ceballos-Baumann A, Piccini P, Boecker H, Harding AE, Brooks DJ (1997) Cortical control of movement in Huntington\u2019s disease. A PET activation study. Brain J Neurol 120(Pt 9):1569\u20131578","journal-title":"Brain J Neurol"},{"key":"8940_CR54","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000222734.56412.17","journal-title":"Neurology"},{"key":"8940_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JHD-130076","volume":"2","author":"EH Aylward","year":"2013","unstructured":"Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2013) Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingt Dis 2:477\u2013489. \n                    https:\/\/doi.org\/10.3233\/JHD-130076","journal-title":"J Huntingt Dis"},{"key":"8940_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/WNR.0b013e3280102302","volume":"18","author":"FA Barrios","year":"2007","unstructured":"Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007) Olfaction and neurodegeneration in HD. Neuroreport 18:73\u201376. \n                    https:\/\/doi.org\/10.1097\/WNR.0b013e3280102302","journal-title":"Neuroreport"},{"key":"8940_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992) Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol 18:539\u2013547","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8940_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a024240","journal-title":"Cold Spring Harb Perspect Med"},{"key":"8940_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/B978-0-12-381328-2.00015-8","volume":"98","author":"L Jones","year":"2011","unstructured":"Jones L, Hughes A (2011) Pathogenic mechanisms in Huntington\u2019s disease. Int Rev Neurobiol 98:373\u2013418. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-381328-2.00015-8","journal-title":"Int Rev Neurobiol"},{"key":"8940_CR60","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1038\/s41598-017-05224-0","volume":"7","author":"RKR Kalathur","year":"2017","unstructured":"Kalathur RKR, Pedro Pinto J, Sahoo B, Chaurasia G, Futschik ME (2017) HDNetDB: a molecular interaction database for network-oriented investigations into Huntington\u2019s disease. Sci Rep 7:5216. \n                    https:\/\/doi.org\/10.1038\/s41598-017-05224-0","journal-title":"Sci Rep"},{"issue":"5","key":"8940_CR61","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of Huntingtin. Neuron 89(5):910\u2013926. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2016.02.003","journal-title":"Neuron"},{"issue":"8","key":"8940_CR62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","volume":"38","author":"J Labbadia","year":"2013","unstructured":"Labbadia J, Morimoto RI (2013) Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38(8):378\u2013385. \n                    https:\/\/doi.org\/10.1016\/j.tibs.2013.05.003","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"8940_CR63","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C, Savage J, Hurlburt A, Cha GH, Ukani L, Chepanoske CL, Zhen Y, Sahasrabudhe S, Olson J, Kurschner C, Ellerby LM, Peltier JM, Botas J, Hughes RE (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 3(5):e82","journal-title":"PLoS Genet"},{"key":"8940_CR64","doi-asserted-by":"publisher","first-page":"21599","DOI":"10.1074\/jbc.M112.359307","volume":"28","author":"BP Culver","year":"2012","unstructured":"Culver BP, Savas JN, Park SK, Choi JH, Zheng S, Zeitlin SO, Yates JR 3rd, Tanese N (2012) Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J Biol Chem 28:21599\u201321614. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.359307","journal-title":"J Biol Chem"},{"key":"8940_CR65","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4161\/cc.20423","volume":"11","author":"T Ratovitski","year":"2012","unstructured":"Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN, Ross CA (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11:2006\u20132021. \n                    https:\/\/doi.org\/10.4161\/cc.20423","journal-title":"Cell Cycle"},{"key":"8940_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","volume":"75","author":"DI Shirasaki","year":"2012","unstructured":"Shirasaki DI, Greiner ER, Al-Ramahi I, Gray M, Boontheung P, Geschwind DH, Botas J, Coppola G, Horvath S, Loo JA, Yang XW (2012) Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75:41\u201357. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2012.05.024","journal-title":"Neuron"},{"key":"8940_CR67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cortex.2013.11.009","volume":"52","author":"MJU Novak","year":"2014","unstructured":"Novak MJU, Seunarine KK, Gibbard CR, Hobbs NZ, Scahill RI, Clark CA, Tabrizi SJ (2014) White matter integrity in premanifest and early Huntington\u2019s disease is related to caudate loss and disease progression. Cortex J Devoted Study Nerv Syst Behav 52:98\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.cortex.2013.11.009","journal-title":"Cortex J Devoted Study Nerv Syst Behav"},{"key":"8940_CR68","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/nbdi.2002.0528","volume":"10","author":"V Macdonald","year":"2002","unstructured":"Macdonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington\u2019s disease. Neurobiol Dis 10:378\u2013386","journal-title":"Neurobiol Dis"},{"key":"8940_CR69","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/brain\/awq047","volume":"133","author":"DCV Thu","year":"2010","unstructured":"Thu DCV, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RLM (2010) Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease. Brain J Neurol 133:1094\u20131110. \n                    https:\/\/doi.org\/10.1093\/brain\/awq047","journal-title":"Brain J Neurol"},{"key":"8940_CR70","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/brain\/awv145","volume":"138","author":"DL Harrington","year":"2015","unstructured":"Harrington DL, Rubinov M, Durgerian S, Mourany L, Reece C, Koenig K, Bullmore E, Long JD, Paulsen JS, PREDICT-HD investigators of the Huntington Study Group, Rao SM (2015) Network topology and functional connectivity disturbances precede the onset of Huntington\u2019s disease. Brain J Neurol 138:2332\u20132346. \n                    https:\/\/doi.org\/10.1093\/brain\/awv145","journal-title":"Brain J Neurol"},{"key":"8940_CR71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00221-002-1291-6","volume":"148","author":"E Seiss","year":"2003","unstructured":"Seiss E, Praamstra P, Hesse CW, Rickards H (2003) Proprioceptive sensory function in Parkinson\u2019s disease and Huntington\u2019s disease: evidence from proprioception-related EEG potentials. Exp Brain Res 148:308\u2013319. \n                    https:\/\/doi.org\/10.1007\/s00221-002-1291-6","journal-title":"Exp Brain Res"},{"key":"8940_CR72","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.jocn.2014.01.019","volume":"21","author":"C-H Cheng","year":"2014","unstructured":"Cheng C-H, Soong B-W, Hsu W-Y, Lin Y-Y (2014) Reduced automatic frontal response to auditory deviance in Huntington\u2019s disease as indexed by magnetic mismatch negativity. J Clin Neurosci Off J Neurosurg Soc Australas 21:1773\u20131778. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2014.01.019","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"8940_CR73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","volume":"79","author":"HH Ruocco","year":"2008","unstructured":"Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F (2008) Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 79:130\u2013135. \n                    https:\/\/doi.org\/10.1136\/jnnp.2007.116244","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8940_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S1355617716000321","volume":"22","author":"I Labuschagne","year":"2016","unstructured":"Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O\u2019Regan A, Queller S, Frost C, Leavitt BR, D\u00fcrr A, Roos R, Owen G, Borowsky B, Tabrizi SJ, Stout JC, TRACK-HD Investigators (2016) Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington\u2019s disease. J Int Neuropsychol Soc JINS 22:595\u2013608. \n                    https:\/\/doi.org\/10.1017\/S1355617716000321","journal-title":"J Int Neuropsychol Soc JINS"},{"key":"8940_CR75","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jns.2011.05.015","volume":"307","author":"SJA van den Bogaard","year":"2011","unstructured":"van den Bogaard SJA, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos R (2011) Shape analysis of subcortical nuclei in Huntington\u2019s disease, global versus local atrophy\u2014results from the TRACK-HD study. J Neurol Sci 307:60\u201368. \n                    https:\/\/doi.org\/10.1016\/j.jns.2011.05.015","journal-title":"J Neurol Sci"},{"key":"8940_CR76","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/mds.23912","volume":"26","author":"DSA Majid","year":"2011","unstructured":"Majid DSA, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM (2011) Basal ganglia atrophy in prodromal Huntington\u2019s disease is detectable over one year using automated segmentation. Mov Disord Off J Mov Disord Soc 26:2544\u20132551. \n                    https:\/\/doi.org\/10.1002\/mds.23912","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8940_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7854_2014_354","volume":"22","author":"HJ Waldvogel","year":"2015","unstructured":"Waldvogel HJ, Kim EH, Tippett LJ, Vonsattel J-PG, Faull RLM (2015) The neuropathology of Huntington\u2019s disease. Curr Top Behav Neurosci 22:33\u201380. \n                    https:\/\/doi.org\/10.1007\/7854_2014_354","journal-title":"Curr Top Behav Neurosci"},{"key":"8940_CR78","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s12311-017-0865-6","volume":"16","author":"PC de Azevedo","year":"2017","unstructured":"de Azevedo PC, Guimar\u00e3es RP, Piccinin CC, Piovesana LG, Campos LS, Zuiani JR, Tamashiro EM, Pinheiro G, Amato-Filho AC, Cendes F, Lopes-Cendes I, D\u2019Abreu A (2017) cerebellar gray matter alterations in huntington disease: a voxel-based morphometry study. Cerebellum Lond Engl 16:923\u2013928. \n                    https:\/\/doi.org\/10.1007\/s12311-017-0865-6","journal-title":"Cerebellum Lond Engl"},{"key":"8940_CR79","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bpa.12115","volume":"24","author":"U R\u00fcb","year":"2014","unstructured":"R\u00fcb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel J-P, Lange H, Korf H-W, den Dunnen W (2014) Huntington\u2019s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol Zurich Switz 24:247\u2013260. \n                    https:\/\/doi.org\/10.1111\/bpa.12115","journal-title":"Brain Pathol Zurich Switz"},{"key":"8940_CR80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mds.10658","volume":"19","author":"J Fielding","year":"2004","unstructured":"Fielding J, Georgiou-Karistianis N, Bradshaw J, Millist L, Churchyard A, Chiu E, White O (2004) Impaired modulation of the vestibulo-ocular reflex in Huntington\u2019s disease. Mov Disord Off J Mov Disord Soc 19:68\u201375. \n                    https:\/\/doi.org\/10.1002\/mds.10658","journal-title":"Mov Disord Off J Mov Disord Soc"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8940-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:03:47Z","timestamp":1589634227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["8940"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8940-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"10 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}